ARQQArqit Quantum Inc.

Nasdaq arqit.uk


$ 0.30 $ 0.00 (1.29 %)    

Tuesday, 17-Sep-2024 14:36:04 EDT
QQQ $ 473.21 $ -2.76 (-0.58 %)
DIA $ 417.06 $ -0.93 (-0.22 %)
SPY $ 562.50 $ -2.63 (-0.47 %)
TLT $ 100.82 $ -0.57 (-0.56 %)
GLD $ 237.34 $ -0.64 (-0.27 %)
$ 0.2863
$ 0.30
$ 0.29 x 600
$ 0.30 x 600
$ 0.30 - $ 0.30
$ 0.27 - $ 0.92
631,897
na
46.83M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-arqit-quantum-maintains-2-price-target

HC Wainwright & Co. analyst Scott Buck reiterates Arqit Quantum (NASDAQ:ARQQ) with a Buy and maintains $2 price target.

 hc-wainwright--co-reiterates-buy-on-arqit-quantum-maintains-2-price-target

HC Wainwright & Co. analyst Scott Buck reiterates Arqit Quantum (NASDAQ:ARQQ) with a Buy and maintains $2 price target.

 arqit-quantum-h1-eps-029-down-from-017-yoy-sales-11900k-up-from-1900k-yoy

Arqit Quantum (NASDAQ:ARQQ) reported quarterly losses of $(0.29) per share. This is a 70.59 percent decrease over losses of $(0...

 hc-wainwright--co-maintains-buy-on-arqit-quantum-lowers-price-target-to-2

HC Wainwright & Co. analyst Scott Buck maintains Arqit Quantum (NASDAQ:ARQQ) with a Buy and lowers the price target from...

Core News & Articles

Arqit Quantum Inc. (NASDAQ:ARQQ, ARQQW)))) (Arqit), a leader in quantum-safe encryption, today announced the creation of the Wo...

 arqits-founder-chairman-and-ceo-david-williams-and-founder-and-cto-david-bestwick-has-agreed-to-purchase-1241379-ordinary-shares-for-0725-per-share-with-total-gross-proceeds-to-arqit-prior-to-the-deduction-of-expenses-of-900000

Arqit Quantum Inc. (NASDAQ:ARQQ, ARQQW)))) (Arqit), a leader in quantum-safe encryption, announced today that D2BW Limited, an ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION